company news about Shatavari Root Extract Gains Attention in Women’s Health Supplement Research

Emerging clinical research highlights the potential role of shatavari in supporting women during the menopausal transition

Shatavari, a traditional botanical known scientifically as Asparagus racemosus, is gaining renewed attention in the dietary supplement industry as interest in women’s health, healthy aging and menopause support continues to grow. A recent randomized clinical study reported that a standardized shatavari root extract was associated with meaningful improvements in menopause-related symptoms among healthy women.

A Traditional Botanical Entering Modern Women’s Health Formulation

Shatavari has long been used in Ayurvedic tradition, particularly as a botanical tonic for women’s reproductive wellness. The plant belongs to the asparagus family and is native to regions of Africa and southern Asia. While its traditional use spans centuries, modern human clinical research on shatavari remains relatively limited compared with more established supplement ingredients.

This gap between traditional use and modern clinical validation is one reason the ingredient is now attracting attention from formulators, researchers and supplement brands. As the women’s health category expands beyond basic multivitamins, botanicals with historical use and emerging clinical support are becoming increasingly relevant.

Study Explores Menopause Symptom Support

The recent study included 60 healthy women between 40 and 55 years of age, including premenopausal, perimenopausal and postmenopausal participants. Subjects consumed either 100 mg of a standardized shatavari root extract or a placebo once daily with an evening meal for eight weeks.

Researchers evaluated changes using the Menopause Rating Scale, a validated tool commonly used to assess menopause-related symptoms across multiple domains. Participants completed assessments at baseline, four weeks and eight weeks. According to the published findings, the shatavari group experienced a substantial reduction in menopause symptom scores compared with placebo.

The study also noted that symptom improvement was observed across different baseline severity groups, suggesting that the botanical may be relevant for women experiencing varying levels of menopausal discomfort. However, as with all emerging nutrition research, additional independent studies with larger sample sizes would help confirm the findings and better define the ingredient’s role in supplement formulation.

Why Menopause Support Is Becoming a Larger Supplement Category

Menopause support has become an increasingly important focus within the global dietary supplement market. Women are seeking more targeted solutions for life-stage wellness, including support for hot flashes, mood balance, sleep quality, energy, comfort and overall quality of life during hormonal transition.

For product developers, this creates an opportunity to formulate products that combine traditional botanical knowledge with modern quality standards. Shatavari is especially interesting because it sits at the intersection of several major supplement trends: women’s health, healthy aging, botanical ingredients and evidence-based product development.

Formulation Considerations for Supplement Brands

For dietary supplement manufacturers and brands, shatavari can be positioned as part of a broader women’s wellness formula rather than as a single “cure-all” ingredient. It may be paired with nutrients and botanicals commonly used in menopause or healthy aging products, such as calcium, vitamin D, magnesium, vitamin B6, phytoestrogen-supportive botanicals, adaptogens or sleep-support ingredients.

Quality control is especially important for botanical ingredients. Brands should consider standardized extracts, identity testing, contaminant screening and transparent sourcing documentation. Standardization helps ensure that each batch delivers a consistent botanical profile, while third-party testing can support consumer trust and regulatory confidence.

Responsible Communication and Compliance

Although the study results are promising, supplement brands should communicate benefits carefully. In most markets, menopause-related supplement claims should avoid disease-treatment language and should instead focus on structure-function style wording, such as “supports women’s wellness during menopause,” “helps support comfort during midlife transition,” or “supports overall female vitality.”

Educational content can also help consumers better understand the difference between traditional use, emerging clinical research and approved health claims. This is especially important in the women’s health category, where consumers often seek both scientific credibility and natural product options.

Industry Outlook

The growing interest in shatavari reflects a broader shift in the supplement industry toward life-stage-specific nutrition. As consumers become more aware of menopause, perimenopause and healthy aging, demand is likely to rise for products that combine botanical heritage, clinical research and high-quality manufacturing.

For formulators, shatavari represents a promising botanical to watch. Its traditional background, emerging human research and relevance to women’s midlife wellness make it a strong candidate for future supplement innovation.